Precision Medicine with Data by Tempus and Eric Lefkofsky

Aug 28, 2017 |

Imagine a world where cancer treatment is tailored according to each patient’s molecular and clinical data. Author Heidi Harris reveals that world may not be far off in her article “Tempus, Eric Lefkofsky, and the Rise of Data-Enabled Precision Medicine“.

The Tech News Spy article reveals that Eric Lefkofsky’s new venture, Tempus, wants to create a paradigm shift in how cancer is treated. With a predicted 14 million diagnoses by 2024, that future can’t come soon enough.

Lefkofsky co-founded Tempus after realizing the gap in medical technology when his wife was diagnosed with cancer. They discovered the process was difficult in part because the physicians did not have access to technology that could accurately interpret the molecular data of each individual.

Tempus seeks to provide that technology to doctors by creating a library of sequenced genomes and clinical data. With access to this library, the physicians will be able to see which medicine and treatment worked well with patients of similar body chemistry and molecular structures and more information click here.

Though genome sequencing has been around since 2003, the technology was prohibitively expensive. The first genome that was sequenced cost over $100 million. With advances to technology, it will soon be available for $5,000 and Tempus hopes to drive that price down even further and learn more about Eric.

Tempus hopes to provide data-enabled precision medicine which will allow doctors to craft precise and effective treatments for each individual. The unique analytics and reporting will provide insights that the physicians can apply immediately to their patients. It also has a unique platform to validate treatment through cell-culture technology, allowing the treatment to be tested on synthetic models and Eric’s lacrosse camp.

Mr. Lefkofsky has been a serial entrepreneur ever since he completed his law degree at the University of Michigan. Though he started with an apparel company, he quickly grew into technology. He co-founded a variety of companies like InnerWorkings and Echo Global Logistics.

However, he is also a philanthropist. He and his wife joined the Giving Pledge in 2013, pledging to donate the majority of their wealth to philanthropic causes. He and his wife also co-founded the Lefkofsky Foundation with the aim of backing educational and scientific causes around the world.

Posted in: Business, Cancer

Comments are closed.